The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Complications due to the use of BMP/INFUSE in spine surgery: The evidence continues to mount
Open accessAbstract
Increasingly, adverse events (AE) attributed to utilizing BMP/INFUSE (Bone Morphogenetic Protein, Medtronic, Memphis, TN, USA) "off-label" in spine surgery are being reported. In 2008, the Food and Drug Administration (FDA) issued a warning that in anterior cervical spine surgery, the "off-label" use of BMP/INFUSE contributed to marked dysphagia, hematoma, seroma, swelling, and/or the need for intubation/tracheostomy. Subsequent studies have cited the following AE; heterotopic ossification (HO), osteolysis, infection, arachnoiditis, increased neurological deficits, retrograde ejaculation, and cancer. Furthermore, in 2011, Carragee et al. noted that 13 of the original industry-sponsored BMP/INFUSE spinal surgery studies failed to acknowledge multiple AE. Additionally, in 2012, Comer et al. observed that the frequency of retrograde ejaculation reported for BMP/INFUSE used "on-label" to perform Anterior Lumbar Interbody Fusion/Lumbar Tapered Fusion-Cage Device (ALIF/LT-Cage) was also largely "under-reported." To summarize, there is mounting evidence in the spinal literature that utilizing BMP/INFUSE in spinal fusions contributes to major perioperative and postoperative morbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carragee, E. J., Hurwitz, E. L., & Weiner, B. K. (2011) · The Spine Journal · doi:10.1016/j.spinee.2011.04.023 · Cited by 1,395
Regulating Off-Label Drug Use — Rethinking the Role of the FDA
Stafford, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0802107 · Cited by 350
Baskin, D. S., Ryan, P., Sonntag, V., Westmark, R., & Widmayer, M. A. (2003) · Spine · doi:10.1097/01.brs.0000065486.22141.ca · Cited by 277
Vaidya, R., Carp, J., Sethi, A., Bartol, S., Craig, J., & Les, C. M. (2007) · European Spine Journal · doi:10.1007/s00586-007-0351-9 · Cited by 257
Carragee, E. J., Mitsunaga, K. A., Hurwitz, E. L., & Scuderi, G. J. (2011) · The Spine Journal · doi:10.1016/j.spinee.2011.02.013 · Cited by 194
The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion
Glassman, S. D., Carreon, L. Y., Campbell, M. J., Johnson, J. R., Puno, R. M., Djurasovic, M., & Dimar, J. R. (2007) · The Spine Journal · doi:10.1016/j.spinee.2007.03.004 · Cited by 124
Trigeminal Neuralgia and Multiple Sclerosis
Brisman, R. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520160021008 · Cited by 122
Bone Morphogenetic Protein in Spine Surgery: Current and Future Uses
Even, J. L., Eskander, M. S., & Kang, J. D. (2012) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/00124635-201209000-00001 · Cited by 116
Comer, G. C., Smith, M. W., Hurwitz, E. L., Mitsunaga, K., Kessler, R., & Carragee, E. J. (2012) · The Spine Journal · doi:10.1016/j.spinee.2012.09.040 · Cited by 115
The use of rhBMP in spine surgery: is there a cancer risk?
DeVine, J. G., Dettori, J. R., France, J. C., Brodt, E., & McGuire, R. (2012) · Evidence-Based Spine-Care Journal · doi:10.1055/s-0031-1298616 · Cited by 115
Arts, M. P., Kols, N. I., Onderwater, S. M., & Peul, W. C. (2012) · Acta Neurochirurgica · doi:10.1007/s00701-012-1380-7 · Cited by 75
High-dose bone morphogenetic protein–induced ectopic abdomen bone growth
Deutsch, H. (2009) · The Spine Journal · doi:10.1016/j.spinee.2009.10.016 · Cited by 74
Update on bone morphogenetic proteins and their application in spine surgery1
Samartzis, D., Khanna, N., Shen, F. H., & An, H. S. (2005) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2004.09.046 · Cited by 55
"Unnecessary" spinal surgery: A prospective 1-year study of one surgeon′s experience
Epstein, N. E., & Hood, D. C. (2011) · Surgical Neurology International · doi:10.4103/2152-7806.82249 · Cited by 47
Self-citationDagostino, P., Whitmore, R. G., Smith, G. A., Maltenfort, M., & Ratliff, J. K. (2012) · The Spine Journal · doi:10.1016/j.spinee.2012.10.035 · Cited by 39
Costs and frequency of "off-label" use of INFUSE for spinal fusions at one institution in 2010
Epstein, N., & Schwall, G. (2011) · Surgical Neurology International · doi:10.4103/2152-7806.83929 · Cited by 17
Self-citationOff-Label Use of Drugs and Devices
Long, D. M., & Watts, C. C. (2013) · Neurosurgery · doi:10.1227/neu.0b013e31828ba778 · Cited by 4
Cited by
A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2
James, A. W., LaChaud, G., Shen, J., Asatrian, G., Nguyen, V., Zhang, X., Ting, K., & Soo, C. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2015.0357 · Cited by 1,131
Eliaz, N., & Metoki, N. (2017) · Materials · doi:10.3390/ma10040334 · Cited by 1,088
Fernandez de Grado, G., Keller, L., Idoux-Gillet, Y., Wagner, Q., Musset, A.-M., Benkirane-Jessel, N., Bornert, F., & Offner, D. (2018) · Journal of Tissue Engineering · doi:10.1177/2041731418776819 · Cited by 912
Bone grafts: which is the ideal biomaterial?
Haugen, H. J., Lyngstadaas, S. P., Rossi, F., & Perale, G. (2019) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13058 · Cited by 573
Tissue Engineering and Cell-Based Therapies for Fractures and Bone Defects
Perez, J. R., Kouroupis, D., Li, D. J., Best, T. M., Kaplan, L., & Correa, D. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00105 · Cited by 390
“In addition to these concerns, major complications have been related to the “offlabeled” use of INFUSE (BMP-2) in spine surgery, most notably being marked dysphagia, seromas and hematomas, swelling, and/or the need for intubation/tracheostomy (Epstein, 2013).”
Background
Metadata
- Authors
- Epstein, N.
- Venue
- Surgical Neurology International
- Publisher
- Scientific Scholar
- Published
- 2013
- Volume
- 4
- Issue
- 6
- Pages
- 343
- ISSN
- 2152-7806 (ISSN-L)
- OpenAlex
- W2023896320
- Cited by
- 252
- References
- 17
- FWCI
- 20.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.